Clinical Trial Update: L9LS-R21 Interaction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating L9LS-R21 for malaria has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• L9LS-R21

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Malaria | Phase 2 | Status: WITHDRAWN